The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Vaccines

Vaccines

Vaccines aim to activate a specific immune response and various peptide/protein vaccines are currently under investigation for tumor treatment. Examples include peptides derived from myeloma-associated antigens, such as mutant Wilms tumor 1 (WT 1), X-box binding protein 1 (XBP1), syndecan-1 (CD138), and CS1 (CD319).

|||